DailyDoctor Archive Specialties Get app
Back to the 23 September 2026 edition

Research · 02 of 06

Congenital CMV screening found 2.5 times more cases; audiology follow-up was the weak link

Test babies who fail the hearing screen for CMV within three weeks of birth, and make sure audiology follow-up actually happens.

Design
Implementation study with retrospective outcome review
Population
50,438 live births in one US health system; 7,491 screened
Primary outcome
Detection of congenital CMV and follow-up
Effect
34 cases (0.45%); ~2.5-fold rise in detection; targeted 0.74% vs universal 0.33%

A Pediatrics report (21 September) describes Cleveland Clinic's hybrid congenital CMV screening programme: universal screening in neonatal intensive care, targeted screening in newborn nurseries (for example after a failed hearing screen). Between 2022 and 2025, 7,491 of 50,438 infants (14.9%) were tested, up from about 150 a year to more than 2,000.

Thirty-four infants (0.45%) had confirmed congenital CMV, about 2.5 times the previous detection. Targeted screening had a higher yield than universal NICU screening (0.74% vs 0.33%). Abnormal neuroimaging (32.3%) and small for gestational age (26.5%) were the commonest findings. Audiology follow-up was limited by logistics, family resources and understanding.

The timing matters: antiviral treatment for symptomatic congenital CMV is started within the first month, so a diagnosis has to be made early. A screen without follow-up does not deliver the benefit.

  • Test for CMV (saliva or urine PCR) within 21 days in any baby failing the newborn hearing screen
  • Consider testing small-for-gestational-age babies and those with microcephaly or unexplained jaundice
  • Refer confirmed cases promptly for assessment and discussion of antiviral treatment
  • Arrange audiology follow-up before discharge and confirm the family can attend

Why it matters

Congenital CMV is the commonest non-genetic cause of childhood deafness and is found only if it is looked for early.

Don't overread it

This is a single-system implementation report, not a trial of outcomes after screening.

The statistics, in plain English

Detection of 0.45% among those tested reflects who was selected for testing, not population prevalence. The difference between targeted and universal groups (P = .01) shows that selecting on risk finds more cases per test.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

neurodevneonatalgrowthpaedemergency

Tomorrow morning, before your first patient

One edition a day for paediatrics, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app